Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Phenethylamin-Derivate

6-APB

C11H13NO CAS 286834-85-3 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
Bevorzugter Name
6-APB
IUPAC-Name
1-(1-benzofuran-6-yl)propan-2-amine
CAS-Nummer der Stammverbindung (Referenz)
286834-85-3
Summenformel
C11H13NO
Molekulargewicht
175.23 g/mol
InChIKey
FQDAMYLMQQKPRX-UHFFFAOYSA-N
PubChem
CID 9794343
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
6-(2-Aminopropyl)benzofuran Benzofury 6APB 6 APB

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

6-APB (Benzofury)

Entactogen / psychedelic (monoamine releaser and 5-HT2B agonist) 6-Substituted benzofuran (primary amine)
Geprüfte PubChem- & CAS-Identität C11H13NO · CAS 286834-85-3 · CID 9794343
Kalibrierte Lieferform Reines Kristall / Analyse-Pulver (≥98 %)
≥98 % analytische Reinheit geprüft 175.23 g/mol
WHO-, PubMed- & PubChem-Quellen 3 cited records

Rezeptor-Telemetrie & Wirkmechanismus

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

6-APB is a 6-benzofuran amphetamine analogue and a monoamine releaser with a more psychedelic edge than MDMA or 5-MAPB. It is also an agonist at 5-HT2B. That receptor is the valvular-heart concern shared with fenfluramine and other chronic 5-HT2B agonists, so frequent repeated use is a different risk from a single spaced exposure. The primary amine lasts longer than N-methyl 5-MAPB.

Biotransformation & Active Metabolites

Not a prodrug of MDA. Succinate is a common salt and is heavier than the freebase (C11H13NO, 175.23 g/mol) or the hydrochloride. PsychonautWiki oral bands should not be copied blindly from one salt onto another. 6-MAPB is the N-methyl analogue and has its own, lower TripSit oral band.

Zeitliche Pharmakokinetik

Long entactogen with a psychedelic tint, more stimulation early and a heavy, warm body later. Less 'clean' than 5-MAPB and much longer.

  1. Onset 30–60 minutes
  2. Peak Window 3–4 hours
  3. Total Window 7–10 hours
  4. Residual / Half-Life After-effects 6–48 hours. PsychonautWiki lists tolerance returning toward baseline only after several weeks for this compound.

Threshold 15 mg, light 30–60 mg, common 60–90 mg, strong 90–120 mg, heavy above 120 mg. Come-up is 60–120 minutes. That slow rise is the entire redose problem: a second dose at one hour arrives during a 3–4 hour peak and a 7–10 hour total course.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
15 mg
Cognitive & Sensory

A mild mood and body shift.

Somatic & Autonomic

Little more than a warm flush.

Light
30–60 mg
Cognitive & Sensory

Soft empathy, light visuals, and stimulation that has not peaked.

Somatic & Autonomic

Nausea, jaw tension, and a rising heart rate.

Common Reference
60–90 mg
Cognitive & Sensory

Full entactogenic and mildly psychedelic effects, music enhancement, and emotional openness over many hours.

Somatic & Autonomic

Bruxism, sweating, dilated pupils, vasoconstriction, and a sustained cardiovascular load.

Strong
90–120 mg
Cognitive & Sensory

Intense visuals for a benzofuran, overwhelming empathy or anxiety, and a very long course.

Somatic & Autonomic

Hyperthermia risk, vomiting, and marked blood-pressure elevation.

Heavy / Toxic Zone
120 mg+
Cognitive & Sensory

A toxic, confused entactogenic state. More material does not fix a come-up that was simply slow.

Somatic & Autonomic

Severe hyperthermia, serotonin toxicity if combined with another releaser, and seizures with tramadol.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

MDMA, 5-MAPB, 4-FA, MDA, and other serotonin releasers

A second releaser on top of a 7–10 hour serotonin releaser is a hyperthermia and serotonin-toxicity combination.

Tramadol and DXM

Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.

Hohes Risiko — Vermeiden

Stimulants, 25x-NBOMe, and hot crowded settings

6-APB already lasts most of a day. Added stimulants, NBOMes, and heat raise hyperthermia, vasoconstriction, and seizure risk.

Alcohol

Worsens dehydration and judgment across a very long course.

Vorsicht / Abschwächung

SSRIs

Blunt the entactogenic phase unevenly. Not a safety factor.

Frequent repeated use via 5-HT2B

Chronic 5-HT2B agonism is the valvular-heart concern. Spacing is part of the risk profile, not only the comedown.

Isomeren- & Strukturvergleich

6-APB is the long primary-amine benzofuran: common 60–90 mg, come-up 1–2 hours, total 7–10 hours, more psychedelic than 5-MAPB. 5-MAPB common is 60–80 mg over 5–8 hours and warmer. 6-MAPB, the N-methyl sibling, is placed by TripSit at a common oral 40–80 mg and is generally described as smoother and less stimulating. All three forbid stacked releasers. Salt mass (succinate versus hydrochloride) moves the real amount inside every one of these bands.

Stabilität & Lagerung

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

PsychonautWiki lists full tolerance with repeated use, a half-reduction on the order of 3–4 weeks, and a return toward baseline around 6–8 weeks, with cross-tolerance to dopaminergic stimulants and, in practice, to other entactogens. That is a longer reset than a weekend stimulant. The crash is serotonergic. Urge to redose during the slow come-up is behavioral, and it is how heavy amounts happen.

Analytische & toxikologische Monographie

6-APB (1-(1-benzofuran-6-yl)propan-2-amine; benzofury; CAS 286834-85-3, PubChem CID 9794343) is the 6-substituted benzofuran primary amine supplied as pure powder or crystals (freebase parent C11H13NO, 175.23 g/mol). It is a monoamine releaser with a psychedelic edge and 5-HT2B agonist activity, the receptor relevant to valvular risk when use is frequent. PsychonautWiki oral bands are threshold 15 mg, light 30–60 mg, common 60–90 mg, strong 90–120 mg, and heavy above 120 mg. Onset is 30–60 minutes, come-up 60–120 minutes, and the total course is 7–10 hours, so a redose at one hour stacks onto the peak. Succinate and hydrochloride do not weigh the same per active molecule. It is longer and more psychedelic than 5-MAPB. Do not combine with MAOIs, MDMA, other releasers, or tramadol.

Chemische Struktur und Molekülprofil

6-APB (1-(1-benzofuran-6-yl)propan-2-amine) ist eine Referenzverbindung aus der Stoffklasse Phenethylamin-Derivate mit der Summenformel C11H13NO und einer molaren Masse von 175.23 g/mol. Die Stammverbindung wird unter der CAS-Nummer 286834-85-3 sowie in der NCBI-PubChem-Datenbank unter CID 9794343 geführt (Standard-InChIKey: FQDAMYLMQQKPRX-UHFFFAOYSA-N).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört 6-APB zur chemischen Klasse Substituted amphetamines, Substituted benzofurans. Toxikologische Hinweise (PsychonautWiki): die genaue toxische Schwelle ist in der Fachliteratur nicht festgelegt. Abhängigkeitspotenzial (PsychonautWiki): mäßiges Abhängigkeitspotenzial bei wiederholter Exposition. Dokumentierte Kreuztoleranz: dopamine, stimulant. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen

Dokumentierte Wechselwirkungen und Kontraindikationen

Hohes Risiko / Gefährliche Kombinationen

Unsichere Kombinationen (erhöhtes Risiko)

Ungeklärte Wechselwirkungen (Vorsicht geboten)